The Belt and Road: Cooperation, Harmony and Win-Win
products

Products

ethyl N-[(2-{[(4-cyanophenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-N-pyridin-2-yl-beta-alaninate CAS:211915-84-3

ethyl N-[(2-{[(4-cyanophenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-N-pyridin-2-yl-beta-alaninate is a compound with a sophisticated molecular structure that suggests diverse pharmacological activities and possible therapeutic applications.


Product Detail

Product Tags

Application and Effect:

The intricate molecular structure of ethyl N-[(2-{[(4-cyanophenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-N-pyridin-2-yl-beta-alaninate hints at its diverse pharmacological potential across various therapeutic areas. One promising avenue for exploration is its potential as an anti-cancer agent in oncology. Studies could focus on its mechanisms of action in inhibiting tumor cell growth, inducing apoptosis, or disrupting cancer-associated signaling pathways. By elucidating its effects on specific cancer types and tumor microenvironments, researchers may uncover novel strategies for combating malignancies and enhancing treatment outcomes for cancer patients. Moreover, ethyl N-[(2-{[(4-cyanophenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-N-pyridin-2-yl-beta-alaninate may hold promise in the realm of neurology, particularly in neurodegenerative diseases like Alzheimer's or Parkinson's. Its molecular profile suggests potential neuroprotective properties or the ability to modulate neuronal function, offering opportunities for developing innovative treatments that target disease-modifying pathways and improve neurological outcomes in patients with neurodegenerative conditions. Additionally, this compound could be explored for its potential therapeutic effects in inflammatory disorders such as rheumatoid arthritis, inflammatory bowel disease, or autoimmune conditions. By targeting inflammatory pathways, immune responses, or cytokine production, ethyl N-[(2-{[(4-cyanophenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-N-pyridin-2-yl-beta-alaninate may demonstrate anti-inflammatory properties that could alleviate symptoms and reduce disease progression in individuals with chronic inflammatory conditions. Overall, the multifaceted pharmacological attributes of ethyl N-[(2-{[(4-cyanophenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-N-pyridin-2-yl-beta-alaninate highlight its potential as a valuable compound for therapeutic innovation and drug discovery. Continued research into its biological activities, mechanisms of action, and therapeutic effects could pave the way for novel treatment strategies and advancements in addressing critical medical needs in various disease states.

Product Sample:

L-Arginine1
L-Arginine2

Product Packing:

L-Arginin3

Additional Information:

Composition C27H26N6O3
Assay 99%
Appearance white powder
CAS No.  211915-84-3
Packing Small and bulk
Shelf Life 2 years
Storage Store in cool and dry area
Certification ISO.

 


  • Previous:
  • Next:

  • Write your message here and send it to us